SWEDEPAD Trials Resurrect the Paclitaxel Death Signal in PAD Interventions

(MedPage Today) — MADRID — Paclitaxel coating added no benefit to balloons and stents for endovascular peripheral arterial disease (PAD) intervention in the SWEDEPAD 1 and 2 trials — and in fact, researchers said they could not ignore a…